Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers-Reference-Cited by-同舟云学术

Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers

Published:2018-09-10 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Egg David,Schwab Charlotte,Gabrysch Annemarie,Arkwright Peter D.,Cheesman Edmund,Giulino-Roth Lisa,Neth Olaf,Snapper Scott,Okada Satoshi,Moutschen Michel,Delvenne Philippe,Pecher Ann-Christin,Wolff Daniel,Kim Yae-Jean,Seneviratne Suranjith,Kim Kyoung-Mee,Kang Ji-Man,Ojaimi Samar,McLean Catriona,Warnatz Klaus,Seidl Maximilian,Grimbacher Bodo

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. Phenotype, penetrance, and treatment of 133 CTLA-4-insufficient individuals;Schwab;J Allergy Clin Immunol.,2018

2. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations;Schubert;Nat Med.,2014

3. Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4;Lee;J Allergy Clin Immunol.,2016

4. Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4;Zeissig;Gut,2015

5. A patient with CTLA-4 haploinsufficiency presenting gastric cancer;Hayakawa;J Clin Immunol.,2016

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Report: Aplastic anemia related to a novel CTLA4 variant;Frontiers in Pediatrics;2024-08-16

2. Infections in Disorders of Immune Regulation;Pathogens;2024-03-17

3. Functional genomics in inborn errors of immunity;Immunological Reviews;2024-02-08

4. Clinical updates in inborn errors of immunity: a focus on the noninfectious clinical manifestations;Current Opinion in Pediatrics;2024-01-22

5. Immunotherapy guided precision medicine in solid tumors;Advances in Protein Chemistry and Structural Biology;2024